Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total operating revenue | 24.18%1.84B | 19.25%1.26B | 19.27%751.9M | 42.40%362.88M | 8.14%1.48B | -7.85%1.05B | -21.10%630.42M | -38.60%254.84M | -15.86%1.37B | -6.72%1.14B |
Operating revenue | 24.18%1.84B | 19.25%1.26B | 19.27%751.9M | 42.40%362.88M | 8.14%1.48B | -7.85%1.05B | -21.10%630.42M | -38.60%254.84M | -15.86%1.37B | -6.72%1.14B |
Other operating revenue | 16.81%10.99M | ---- | 29.35%6.87M | ---- | -17.16%9.4M | ---- | -22.16%5.31M | ---- | 104.68%11.35M | ---- |
Total operating cost | 22.32%1.81B | 15.54%1.23B | 11.13%728.55M | 17.64%356.46M | 6.38%1.48B | -5.53%1.07B | -15.25%655.59M | -25.53%303.01M | -11.47%1.39B | -4.33%1.13B |
Operating cost | 25.27%1.65B | 15.59%1.1B | 11.08%649.18M | 23.79%316.79M | 3.08%1.31B | -9.66%952.95M | -18.55%584.44M | -30.03%255.92M | -10.78%1.28B | -2.28%1.05B |
Operating tax surcharges | 6.99%14.98M | 24.15%11.75M | 19.86%7.99M | 18.67%3.33M | 49.92%14M | 49.44%9.46M | 60.83%6.66M | 64.12%2.81M | 30.03%9.34M | 23.38%6.33M |
Operating expense | 0.93%21.65M | 16.94%15.6M | 31.74%9.85M | 33.64%4.4M | 25.85%21.45M | 2.10%13.34M | -4.63%7.48M | -28.35%3.29M | 27.43%17.05M | 37.98%13.07M |
Administration expense | 5.80%58.23M | 9.43%43.77M | 15.37%29.89M | 10.84%15.17M | 34.49%55.04M | 19.93%40M | 20.51%25.9M | 37.14%13.69M | -4.99%40.93M | 1.74%33.35M |
Financial expense | -62.13%9.29M | 35.60%16.92M | 5.02%6.14M | -68.15%4.19M | 240.50%24.54M | 138.95%12.47M | 138.97%5.84M | 224.00%13.14M | -215.61%-17.47M | -617.25%-32.02M |
-Interest expense (Financial expense) | -6.31%29.55M | -6.06%21.56M | 17.69%17.3M | 16.36%8.39M | 48.47%31.54M | 72.86%22.96M | 155.09%14.7M | 158.00%7.21M | 217.67%21.24M | 187.60%13.28M |
-Interest Income (Financial expense) | 52.21%-1.69M | 45.78%-1.3M | 48.99%-772.66K | 56.71%-388.47K | -39.31%-3.55M | -33.78%-2.4M | -87.90%-1.51M | -94.21%-897.28K | -79.07%-2.55M | -96.66%-1.79M |
Research and development | 18.10%63.51M | 11.33%42.52M | 1.01%25.52M | -11.19%12.58M | -22.36%53.78M | -28.35%38.2M | -32.83%25.26M | -31.93%14.17M | 3.33%69.27M | 13.40%53.31M |
Credit Impairment Loss | -34.68%-4.45M | 62.62%-849.37K | 145.99%1.46M | 21.85%2.23M | -160.98%-3.31M | -176.40%-2.27M | -294.26%-3.18M | 232.89%1.83M | 354.49%5.42M | 1,196.38%2.97M |
Asset Impairment Loss | 45.53%-20.74M | -36.97%-21.87M | -2,540.20%-19.13M | -123.78%-3.53M | -13.69%-38.06M | -142.15%-15.96M | 82.04%-724.43K | 19,280.27%14.84M | -129.38%-33.48M | 28.22%-6.59M |
Other net revenue | 54.50%-19.35M | 35.02%-19.36M | -75.83%-18.28M | -117.66%-3.77M | -369.98%-42.52M | -1,417.33%-29.8M | -461.98%-10.4M | 553.53%21.34M | -21.26%-9.05M | 36.51%-1.96M |
Fair value change income | 126.56%3.11M | 92.95%-1.58M | 89.49%-1.85M | 14.27%-3.11M | -233.96%-11.71M | -262.68%-22.33M | ---17.56M | ---3.63M | --8.74M | ---6.16M |
Invest income | -131.86%-6.19M | -298.64%-2.11M | -192.67%-2.44M | -115.66%-1.11M | 37.45%-2.67M | 158.08%1.06M | --2.63M | --7.1M | -236.21%-4.27M | -84.99%412.25K |
-Including: Investment income associates | 123.66%4.14K | ---- | ---- | ---- | ---17.49K | ---- | ---- | ---- | ---- | ---- |
Asset deal income | 97.87%-19.22K | 99.92%-517.11 | 94.69%-12.95K | 88.01%-24.4K | -520.65%-904.11K | -1,800.28%-646.42K | -367.38%-243.9K | -289.75%-203.58K | 178.78%214.93K | 42.38%-34.02K |
Other revenue | -36.75%8.94M | -31.97%7.04M | -57.58%3.68M | 26.20%1.78M | -1.34%14.13M | 39.24%10.35M | 63.14%8.68M | -50.56%1.41M | 123.72%14.32M | 102.24%7.43M |
Operating profit | 121.50%9.01M | 115.48%6.41M | 114.25%5.07M | 109.91%2.66M | -34.24%-41.94M | -397.72%-41.4M | -225.55%-35.57M | -335.26%-26.83M | -164.69%-31.24M | -68.45%13.91M |
Add:Non operating Income | -56.29%167.03K | -76.75%52.76K | -81.69%36.2K | -84.18%19.08K | -90.81%382.15K | -94.14%226.94K | -94.85%197.68K | 6.51%120.61K | -69.96%4.16M | -71.61%3.87M |
Less:Non operating expense | 2,635.19%1.15M | 83.04%1.05M | 1,695.81%215.3K | 572.26%41.11K | -99.08%42.13K | -57.50%575.61K | -21.11%11.99K | --6.12K | 420.30%4.58M | 307.75%1.35M |
Total profit | 119.30%8.03M | 112.95%5.41M | 113.82%4.89M | 109.87%2.64M | -31.37%-41.6M | -354.23%-41.75M | -210.03%-35.38M | -331.96%-26.72M | -151.69%-31.66M | -71.38%16.42M |
Less:Income tax cost | 72.60%-1.21M | 98.65%-169.51K | 105.55%470.83K | 84.16%-718.56K | -73.20%-4.41M | -105.60%-12.51M | -33,043.29%-8.49M | -300.29%-4.54M | -17.85%-2.54M | -285.86%-6.09M |
Net profit | 124.84%9.24M | 119.07%5.58M | 116.43%4.42M | 115.12%3.35M | -27.72%-37.19M | -229.88%-29.23M | -183.70%-26.89M | -275.31%-22.18M | -145.92%-29.12M | -58.39%22.51M |
Net profit from continuing operation | 124.84%9.24M | 119.07%5.58M | 116.43%4.42M | 115.12%3.35M | -27.72%-37.19M | -229.88%-29.23M | -183.70%-26.89M | -275.31%-22.18M | -145.92%-29.12M | -58.39%22.51M |
Less:Minority Profit | 52.63%-1.03M | 58.64%-586.76K | 25.17%-681.62K | 7.48%-262.94K | -71.45%-2.18M | -141.66%-1.42M | -210.46%-910.94K | 0.52%-284.19K | -1,040.25%-1.27M | ---587.02K |
Net profit of parent company owners | 129.33%10.27M | 122.16%6.16M | 119.63%5.1M | 116.52%3.62M | -25.72%-35.01M | -220.44%-27.82M | -180.13%-25.98M | -269.25%-21.89M | -143.84%-27.85M | -57.31%23.1M |
Earning per share | ||||||||||
Basic earning per share | 122.22%0.06 | 119.05%0.04 | 120.00%0.04 | 135.29%0.06 | -28.57%-0.27 | -220.00%-0.21 | -183.33%-0.2 | -270.00%-0.17 | -141.18%-0.21 | -60.86%0.175 |
Diluted earning per share | 150.00%0.06 | 136.27%0.037 | 125.00%0.03 | 153.85%0.07 | 14.29%-0.12 | -152.55%-0.102 | -150.00%-0.12 | -230.00%-0.13 | -127.45%-0.14 | -56.59%0.1941 |
Other composite income | -980.74%-104.01K | -203.65K | -5,295.66%-91.96K | 50.00%-1.23K | -53.12%11.81K | -81.41%1.77K | 5.03%-2.46K | 249.88%25.19K | ||
Other composite income of parent company owners | -980.74%-104.01K | ---203.65K | -5,295.66%-91.96K | 50.00%-1.23K | -53.12%11.81K | ---- | -81.41%1.77K | 5.03%-2.46K | 249.88%25.19K | ---- |
Other composite income of minority owners | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Total composite income | 124.56%9.13M | 118.38%5.37M | 116.09%4.33M | 115.12%3.35M | -27.79%-37.18M | -229.88%-29.23M | -183.67%-26.89M | -275.37%-22.18M | -145.88%-29.09M | -58.40%22.51M |
Total composite income of parent company owners | 129.04%10.16M | 121.42%5.96M | 119.28%5.01M | 116.51%3.62M | -25.79%-35M | -220.44%-27.82M | -180.84%-25.98M | -269.30%-21.9M | -143.80%-27.82M | -57.31%23.1M |
Total composite income of minority owners | 52.63%-1.03M | 58.64%-586.76K | 25.17%-681.62K | 7.48%-262.94K | -71.45%-2.18M | -141.66%-1.42M | ---910.94K | 0.52%-284.19K | -1,040.25%-1.27M | ---587.02K |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
Auditor | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.